Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion

F. Di Filippo, A. Calabro, D. Giannarelli, S. Carlini, F. Cavaliere, F. Moscarelli, R. Cavaliere

Research output: Contribution to journalArticlepeer-review

Abstract

Between October 1969 and December 1986, 136 patients with recurrent limb melanoma were treated with hyperthermic antiblastic perfusion (HAP). This retrospective analysis is aimed at identifying tumor-related and treatment-related variables likely to influence tumor response, locoregional control, disease-free survival, and overall survival. Independent factors predicting a complete response (CR) were the number of lesions (P

Original languageEnglish
Pages (from-to)2551-2561
Number of pages11
JournalCancer
Volume63
Issue number12
Publication statusPublished - 1989

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint

Dive into the research topics of 'Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion'. Together they form a unique fingerprint.

Cite this